Y-mAbs Therapeutics, Inc.

GEODE CAPITAL MANAGEMENT, LLC

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/8/2025

Shares

848,461

Value ($000)

3,827

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/8/2025	3,827	0.0%	848,461	6/30/2025
2025 Q1	5/13/2025	3,764	0.0%	849,500	3/31/2025
2024 Q4	2/12/2025	6,440	0.0%	822,309	12/31/2024
2024 Q3	11/12/2024	10,699	0.0%	813,489	9/30/2024
2024 Q2	8/9/2024	9,251	0.0%	765,643	6/30/2024
2024 Q1	5/13/2024	12,079	0.0%	742,749	3/31/2024
2023 Q4	2/13/2024	5,037	0.0%	738,548	12/31/2023
2023 Q3	11/13/2023	3,874	0.0%	710,833	9/30/2023
2023 Q2	8/11/2023	4,832	0.0%	711,664	6/30/2023
2023 Q1	5/15/2023	3,320	0.0%	662,645	3/31/2023
2022 Q4	2/13/2023	3,080	0.0%	631,294	12/31/2022
2022 Q3	11/14/2022	9,126	0.0%	632,895	9/30/2022
2022 Q2	8/12/2022	9,473	0.0%	626,168	6/30/2022
2022 Q1	5/13/2022	6,932	0.0%	583,529	3/31/2022
2021 Q4	2/11/2022	10,066	0.0%	620,977	12/31/2021
2021 Q3	11/12/2021	16,470	0.0%	577,111	9/30/2021
2021 Q2	8/13/2021	18,625	0.0%	551,047	6/30/2021
2021 Q1	5/12/2021	14,337	0.0%	474,118	3/31/2021
2020 Q4	2/12/2021	21,332	0.0%	430,878	12/31/2020
2020 Q3	11/13/2020	15,401	0.0%	401,177	9/30/2020
2020 Q2	8/13/2020	15,489	0.0%	358,563	6/30/2020
2020 Q1	5/14/2020	8,021	0.0%	307,322	3/31/2020
2019 Q4	2/13/2020	8,506	0.0%	272,218	12/31/2019